![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
Kering falls 5.42% at market open after weak Q1 results; Q2 expected to stay tough
Shares of French luxury group Kering dropped 5.42% at market open on Thursday, following weaker-than-expected Q1 results and a cautious Q2 outlook, reflecting investor concern over Gucci.
Shares of French luxury group Kering dropped 5.42% at market open on Thursday, following weaker-than-expected Q1 results and a cautious Q2 outlook, reflecting investor concern over Gucci.
